Literature DB >> 23686365

Diagnostic value of immunohistochemical staining of GP73, GPC3, DCP, CD34, CD31, and reticulin staining in hepatocellular carcinoma.

Shuzhe Yao1, Jianping Zhang, Haiyan Chen, Yan Sheng, Xiaoying Zhang, Zhiyan Liu, Cuijuan Zhang.   

Abstract

It has been reported that Golgi protein-73 (GP73), glypican-3 (GPC3), and des-γ-carboxy prothrombin (DCP) could serve as serum markers for the early detection of hepatocellular carcinoma (HCC). This study aimed to evaluate a panel of immunostaining markers (including GP73, GPC3, DCP, CD34, and CD31) as well as reticulin staining to distinguish HCC from the mimickers. Our results revealed that CD34 immunostaining and reticulin staining were highly sensitive for the diagnosis of HCC. A special immunoreaction pattern of GP73--a diffuse coarse-block pattern in a perinuclear region or a concentrated cluster-like or cord-like pattern in a certain part of the cytoplasm--was observed in HCC cells, in contrast to the cytoplasmic fine-granular pattern in surrounding non-tumor cells and non-malignant nodules. This coarse-block pattern correlated significantly with less differentiated HCC. In comparison, GPC3 displayed a good advantage in diagnosing well-differentiated HCC. In our study, DCP and CD31 showed little diagnostic value for HCC as an immunostaining marker. When GP73, GPC3, and CD34 were combined, the specificity improved to 96.6%. Our findings demonstrate for the first time that the immunohistochemical panel of GP73, GPC3, and CD34 as well as reticulin staining is highly specific for the pathological diagnosis of HCC.

Entities:  

Keywords:  CD34; GP73; GPC3; hepatocellular carcinoma; immunohistochemistry

Mesh:

Substances:

Year:  2013        PMID: 23686365      PMCID: PMC3753886          DOI: 10.1369/0022155413492771

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  55 in total

1.  Expression of GPC3, an X-linked recessive overgrowth gene, is silenced in malignant mesothelioma.

Authors:  S S Murthy; T Shen; A De Rienzo; W C Lee; P C Ferriola; S C Jhanwar; B T Mossman; J Filmus; J R Testa
Journal:  Oncogene       Date:  2000-01-20       Impact factor: 9.867

2.  Glypican-3 expression in hepatocellular tumors: diagnostic value for preneoplastic lesions and hepatocellular carcinomas.

Authors:  Xiao Ying Wang; Françoise Degos; Sylvie Dubois; Sandrine Tessiore; Mark Allegretta; Ronald D Guttmann; Serge Jothy; Jacques Belghiti; Pierre Bedossa; Valérie Paradis
Journal:  Hum Pathol       Date:  2006-08-10       Impact factor: 3.466

3.  Golgi protein 73 (GOLPH2) is a valuable serum marker for hepatocellular carcinoma.

Authors:  Yilei Mao; Huayu Yang; Haifeng Xu; Xin Lu; Xinting Sang; Shunda Du; Haitao Zhao; Wang Chen; Yiyao Xu; Tianyi Chi; Zhiying Yang; Jianqiang Cai; Hui Li; Jianguo Chen; Shouxian Zhong; Smruti R Mohanti; Reynold Lopez-Soler; J Michael Millis; Jiefu Huang; Hongbing Zhang
Journal:  Gut       Date:  2010-09-28       Impact factor: 23.059

Review 4.  Evolving molecular mechanism-based strategies for control of hepatocellular carcinoma.

Authors:  K Sato; M Mori
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

5.  Golgi protein 73(GP73), a useful serum marker in liver diseases.

Authors:  Xiangyi Liu; Xiaohua Wan; Zhongwu Li; Changqing Lin; Yutao Zhan; Xinxin Lu
Journal:  Clin Chem Lab Med       Date:  2011-06-10       Impact factor: 3.694

6.  Expression of cell-cell and cell-matrix adhesion proteins by sinusoidal endothelial cells in the normal and cirrhotic human liver.

Authors:  A Couvelard; J Y Scoazec; G Feldmann
Journal:  Am J Pathol       Date:  1993-09       Impact factor: 4.307

Review 7.  The cell adhesion molecules of hepatic sinusoidal endothelial cells.

Authors:  J Y Scoazec; G Feldmann
Journal:  J Hepatol       Date:  1994-02       Impact factor: 25.083

8.  Serological AFP/Golgi protein 73 could be a new diagnostic parameter of hepatic diseases.

Authors:  Liyuan Tian; Yu Wang; Dabin Xu; Junhao Gui; Xingwang Jia; Hongli Tong; Xinyu Wen; Zhennan Dong; Yaping Tian
Journal:  Int J Cancer       Date:  2011-03-11       Impact factor: 7.396

9.  Expression of GP73, a resident Golgi membrane protein, in viral and nonviral liver disease.

Authors:  Raleigh D Kladney; Xiaoyen Cui; Gary A Bulla; Elizabeth M Brunt; Claus J Fimmel
Journal:  Hepatology       Date:  2002-06       Impact factor: 17.425

10.  Golgi phosphoprotein 2 (GOLPH2) expression in liver tumors and its value as a serum marker in hepatocellular carcinomas.

Authors:  Marc-Oliver Riener; Frank Stenner; Heike Liewen; Christopher Soll; Stefan Breitenstein; Bernhard Cornelius Pestalozzi; Panagiotis Samaras; Nicole Probst-Hensch; Claus Hellerbrand; Beat Müllhaupt; Pierre-Alain Clavien; Marcus Bahra; Peter Neuhaus; Peter Wild; Florian Fritzsche; Holger Moch; Wolfram Jochum; Glen Kristiansen
Journal:  Hepatology       Date:  2009-05       Impact factor: 17.425

View more
  18 in total

1.  Complement factor H-deficient mice develop spontaneous hepatic tumors.

Authors:  Jennifer Laskowski; Brandon Renner; Matthew C Pickering; Natalie J Serkova; Peter M Smith-Jones; Eric T Clambey; Raphael A Nemenoff; Joshua M Thurman
Journal:  J Clin Invest       Date:  2020-08-03       Impact factor: 14.808

2.  Development of a Time-Resolved Fluorescence Immunoassay for the Diagnosis of Hepatocellular Carcinoma Based on the Detection of Glypican-3.

Authors:  Juan-Juan Chen; Chun-Mei Xie; Cong-Rong Wang; Yong Wan; Zhi-Ning Dong; Ming Li; Wei-Wen Xu
Journal:  J Fluoresc       Date:  2017-04-20       Impact factor: 2.217

Review 3.  Proteoglycans in liver cancer.

Authors:  Kornélia Baghy; Péter Tátrai; Eszter Regős; Ilona Kovalszky
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

4.  Effect of BZG-4000, a novel multi-targeted kinase inhibitor with potent anticancer activity, on a hepatocellular carcinoma xenograft model.

Authors:  Yun-Qing Qiu; Jue Zhou; Xin-Shan Kang; Lie-Ming Ding; Wei Yu; Fen-Lai Tan; Dan-Feng Deng
Journal:  Sci Rep       Date:  2014-03-17       Impact factor: 4.379

5.  EpCAM+ Liver Cancer Stem-Like Cells Exhibiting Autocrine Wnt Signaling Potentially Originate in Cirrhotic Patients.

Authors:  Ritu Khosla; Archana Rastogi; Gayatri Ramakrishna; Viniyendra Pamecha; Ashok Mukhopadhyay; Madavan Vasudevan; Shiv Kumar Sarin; Nirupma Trehanpati
Journal:  Stem Cells Transl Med       Date:  2017-01-18       Impact factor: 6.940

6.  Hepatitis B Virus X Protein-Induced Serine Protease Inhibitor Kazal Type 1 Is Associated with the Progression of HBV-Related Diseases.

Authors:  Chengliang Zhu; Huan Han; Jie Li; Limin Xu; Fang Liu; Kailang Wu; Xinghui Liu
Journal:  Biomed Res Int       Date:  2019-05-22       Impact factor: 3.411

7.  Normal Alpha-Fetoprotein Hepatocellular Carcinoma: Are They Really Normal?

Authors:  Chao-Wei Lee; Hsin-I Tsai; Wei-Chen Lee; Shu-Wei Huang; Cheng-Yu Lin; Yi-Chung Hsieh; Tony Kuo; Chun-Wei Chen; Ming-Chin Yu
Journal:  J Clin Med       Date:  2019-10-19       Impact factor: 4.241

8.  Role of FNA and Core Biopsy of Primary and Metastatic Liver Disease.

Authors:  John P McGahan; John Bishop; John Webb; Lydia Howell; Natalie Torok; Ramit Lamba; Michael T Corwin
Journal:  Int J Hepatol       Date:  2013-11-21

Review 9.  Golgi protein 73 and its diagnostic value in liver diseases.

Authors:  Yanyan Xia; Yuanying Zhang; Mengjiao Shen; Hongpan Xu; Zhiyang Li; Nongyue He
Journal:  Cell Prolif       Date:  2018-10-19       Impact factor: 6.831

10.  Muscle metabolomics analysis reveals potential biomarkers of exercise‑dependent improvement of the diaphragm function in chronic obstructive pulmonary disease.

Authors:  Jian Li; Yufan Lu; Ning Li; Peijun Li; Jianqing Su; Zhengrong Wang; Ting Wang; Zhaoyu Yang; Yahui Yang; Haixia Chen; Lu Xiao; Hongxia Duan; Weibing Wu; Xiaodan Liu
Journal:  Int J Mol Med       Date:  2020-03-12       Impact factor: 4.101

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.